Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Unilever plc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.14 (market cap $4.02B), while Unilever plc trades at $64.85 (market cap $137.84B). The key difference: Unilever plc is far larger — about 34.3× Edgewise Therapeutics Inc. Common Stock's market cap, and Unilever plc pays a 3.32% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Unilever plc for 112 Days on average.
| EWTX | UL | |
|---|---|---|
Market Cap | $4.02B | $137.84B |
Volume | 1,446,128 | 2,711,415 |
Sector | Health | Consumer Staples |
52-Week High | $48.35 | $74.59 |
52-Week Low | $14.89 | $55.05 |
Typical Hold Time | 0 Days | 112 Days |
Enterprise Value | $3.56B | $162.87B |
Dividend Yield | — | 3.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Unilever (UL) trades at $62.49, down 0.73% with a bullish technical signal despite recent earnings misses. The company shows strong profitability with 18.32% net margins and 54.56% ROE, though revenue declined to $50.5B in 2025. Recent news highlights the planned $65B food business merger with McCormick facing regulatory scrutiny while the company focuses on beauty and personal care segments.
UL presents a mixed outlook with strong fundamentals offset by execution risks. The 26.32% buy rating and $66.08 consensus target suggest modest upside potential, but investors face headwinds from competitive pressures and integration challenges from the McCormick deal. The stock's current valuation at 21.87 P/E appears reasonable given its defensive characteristics and emerging market exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
